We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+6.57%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$49.1B
AUM Growth
+$4.31B
Cap. Flow
+$1.72B
Cap. Flow %
3.51%
Top 10 Hldgs %
14.46%
Holding
3,114
New
67
Increased
2,155
Reduced
468
Closed
57

Sector Composition

Rank Sector Weight
1 Financials 14.36%
2 Healthcare 13.62%
3 Technology 13.02%
4 Industrials 11.1%
5 Energy 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCBC
2951
DELISTED
Macatawa Bank Corp
MCBC
$181K ﹤0.01%
33,800
NMRX
2952
DELISTED
Numerex Corp
NMRX
$181K ﹤0.01%
16,600
ACHV icon
2953
Achieve Life Sciences
ACHV
$633M
$179K ﹤0.01%
9
CYNI
2954
DELISTED
CYAN INC COM
CYNI
$177K ﹤0.01%
17,489
+873
+5% +$8.72K
SYUT
2955
DELISTED
Synutra International, Inc.
SYUT
$176K ﹤0.01%
32,700
-4,148
-11% -$20.6K
MDCI
2956
DELISTED
MEDICAL ACTION INDS INC
MDCI
$176K ﹤0.01%
26,950
HEOP
2957
DELISTED
Heritage Oaks Bancorp
HEOP
$176K ﹤0.01%
27,600
IMI
2958
DELISTED
Intermolecular, Inc.
IMI
$174K ﹤0.01%
31,158
+1,746
+6% +$11K
MERC icon
2959
Mercer International
MERC
$40.5M
$173K ﹤0.01%
23,206
-1,182
-5% -$8.17K
GMO
2960
DELISTED
General Moly, Inc.
GMO
$173K ﹤0.01%
106,000
-38,744
-27% -$69.9K
GUID
2961
DELISTED
Guidance Software, Inc.
GUID
$172K ﹤0.01%
18,600
-8,512
-31% -$74.5K
CRTX
2962
DELISTED
CORNERSTONE THERAPEUTICS INC
CRTX
$172K ﹤0.01%
18,100
RGLS
2963
DELISTED
Regulus Therapeutics
RGLS
$168K ﹤0.01%
151
REXI
2964
DELISTED
RESOURCE AMERICA INC CL-A
REXI
$168K ﹤0.01%
20,500
HMTV
2965
DELISTED
Hemisphere Media Group, Inc.
HMTV
$167K ﹤0.01%
13,942
+194
+1% +$2.5K
AVEO
2966
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$167K ﹤0.01%
8,000
-2,380
-23% -$54.5K
SALM
2967
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$165K ﹤0.01%
19,800
UCP
2968
DELISTED
UCP, Inc.
UCP
$164K ﹤0.01%
+11,100
New +$155K
TAST
2969
DELISTED
Carrols Restaurant Group, Inc.
TAST
$163K ﹤0.01%
26,300
RVLT
2970
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$163K ﹤0.01%
4,230
ESSA
2971
DELISTED
ESSA Bancorp
ESSA
$161K ﹤0.01%
15,200
MITK icon
2972
Mitek Systems
MITK
$756M
$161K ﹤0.01%
31,700
LMIA
2973
DELISTED
LMI Aerospace Inc
LMIA
$161K ﹤0.01%
12,300
-6,100
-33% -$95.3K
GSE
2974
DELISTED
GSE HLDG INC COM STK (DE)
GSE
$161K ﹤0.01%
75,700
+64,900
+601% +$223K
ZAGG
2975
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$159K ﹤0.01%
35,000

Similar funds

Charles Schwab's Q3 2013 Portfolio in Review

As of Q3 2013, Charles Schwab held 3,114 positions worth $49.1B, up 9.6% from $44.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab deployed $1.72B of net new capital in Q3 2013, opening 67 new positions and adding to 2,155 existing holdings. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 4,003,512 shares worth $136M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Merck, an estimated $76M trimmed.

  • Charles Schwab's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 4,003,512 shares worth $136M.
  • Charles Schwab added most to Johnson & Johnson in Q3 2013, an estimated $125M increase.
  • Charles Schwab's biggest Q3 2013 reduction was Merck, cutting an estimated $76M.
  • Charles Schwab fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $47.2M.
  • Charles Schwab's ten largest holdings make up 14% of its $49.1B portfolio in Q3 2013.
  • Charles Schwab opened 67 new positions and closed 57 in Q3 2013.
  • Charles Schwab's portfolio value rose 9.6% quarter-over-quarter to $49.1B.

Based on Charles Schwab's 13F filing for Q3 2013, filed 14 Nov 2013.